GRIMALDI CLAUDIA — SEC Form 4 filings

SEC reporting owner CIK 1745853. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-15 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IGC Pharma, Inc. (IGC)PFO, Director418

Form 4 filings — GRIMALDI CLAUDIA

FiledFormIssuerReported transactionsSource
2026-07-014IGC Pharma, Inc. (IGC)Grant/award (A): 2,048,378 @ $0.27EDGAR
2026-04-064IGC Pharma, Inc. (IGC)Option exercise (M): 100,000 @ $0 · Option exercise (M): 138,462 @ $0.26 · Option exercise (M): 100,000 (derivative) @ $0 · Option exercise (M): 138,462 (derivative) @ $0EDGAR
2025-10-214IGC Pharma, Inc. (IGC)Gift (G): 50,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2024-03-154IGC Pharma, Inc. (IGC)Option exercise (M): 83,333 @ $0 · Option exercise (M): 58,333 @ $0 · Option exercise (M): 100,000 @ $0 · Option exercise (M): 95,000 @ $0 · Option exercise (M): 83,333 (derivative) @ $0 · Option exercise (M): 58,334 (derivative) @ $0 · +4 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1745853 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →